CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 112 enrolled
Drug / intervention
Fully covered Metallic Stent +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01221311
NCT01221311N/ACompleted

Use of Fully-covered, Self-expandable Metallic Stents for First-line Treatment of Benign Bile Duct Strictures

Medical University of South Carolina·interventional·Posted Oct 15, 2010·Updated Jun 2, 2017

In Brief

A clinical study evaluating Fully covered Metallic Stent and Plastic Stent for Common Bile Duct Stricture. Completed, enrolled 112 participants across 8 sites in 2 countries.

Detailed Summary

The current standard of care for benign bile duct strictures involves placement of multiple plastic stents under endoscopic and fluoroscopic guidance to progressively dilate or stretch it open. This approach necessitates multiple procedures which may extend over one year before the stricture is adequately dilated. The investigators propose a study comparing the standard approach of plastic stenting with the use of newer, fully coated metallic stents which are self-expandable, thereby permitting successful dilation of benign bile duct strictures with fewer procedures.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited Kingdom, United States

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedOct 15, 2010
Enrollment StartJan 1, 2011
Primary CompletionOct 1, 2015
Study CompletionOct 1, 2016
TodayJul 2, 2026
Enrollment to primary: 4.8 yearsPosted 15.7 years ago

Interventions

Fully covered Metallic Stentdevice

Covered Wallflex Biliary (TM)

Plastic Stentdevice

Patients randomized to the PS group will be treated using a standard algorithm. Specifically, the stricture will be dilated using a passage dilator and/or dilation balloon catheter, and one or two PS will be deployed depending on the baseline characteristics of the stricture as well as the diameter of the proximal and distal bile duct (standard of care). The endoscopist will sequentially dilate and upsize the cumulative stent diameter on ensuing ERCPs, until the stricture has been obliterated using clinical and fluoroscopic criteria.